These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 8397242

  • 1. Differences in growth characteristics of vascular smooth muscle from spontaneously hypertensive and Wistar-Kyoto rats are growth factor dependent.
    Saltis J, Agrotis A, Bobik A.
    J Hypertens; 1993 Jun; 11(6):629-37. PubMed ID: 8397242
    [Abstract] [Full Text] [Related]

  • 2. Developmental regulation of transforming growth factor-beta 1 responses and vascular smooth muscle growth in spontaneously hypertensive rats.
    Saltis J, Bobik A.
    J Hypertens; 1995 Dec; 13(12 Pt 1):1441-8. PubMed ID: 8866906
    [Abstract] [Full Text] [Related]

  • 3. Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats.
    Satoh C, Fukuda N, Hu WY, Nakayama M, Kishioka H, Kanmatsuse K.
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):108-18. PubMed ID: 11152368
    [Abstract] [Full Text] [Related]

  • 4. Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats.
    Fukuda N, Hu WY, Teng J, Chikara S, Nakayama M, Kishioka H, Kanmatsuse K.
    Atherosclerosis; 2002 Aug; 163(2):229-39. PubMed ID: 12052469
    [Abstract] [Full Text] [Related]

  • 5. Role of long-form PDGF A-chain in the growth of vascular smooth muscle cells from spontaneously hypertensive rats.
    Fukuda N, Kishioka H, Satoh C, Nakayama T, Watanabe Y, Soma M, Izumi Y, Kanmatsuse K.
    Am J Hypertens; 1997 Oct; 10(10 Pt 1):1117-24. PubMed ID: 9370382
    [Abstract] [Full Text] [Related]

  • 6. Low dose of eicosapentaenoic acid inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats through suppression of transforming growth factor-beta.
    Nakayama M, Fukuda N, Watanabe Y, Soma M, Hu WY, Kishioka H, Satoh C, Kubo A, Kanmatsuse K.
    J Hypertens; 1999 Oct; 17(10):1421-30. PubMed ID: 10526902
    [Abstract] [Full Text] [Related]

  • 7. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats.
    Fukuda N, Hu WY, Satoh C, Nakayama M, Kishioka H, Kubo A, Kanmatsuse K.
    J Hypertens; 1999 Aug; 17(8):1099-107. PubMed ID: 10466465
    [Abstract] [Full Text] [Related]

  • 8. Characteristics and expression of transforming growth factor-beta receptor subtypes on vascular smooth muscle cells from spontaneously hypertensive rats.
    Fukuda N, Kubo A, Izumi Y, Soma M, Kanmatsuse K.
    J Hypertens; 1995 Aug; 13(8):831-7. PubMed ID: 8557960
    [Abstract] [Full Text] [Related]

  • 9. Effect of transforming growth factor-beta 1 on platelet-derived growth factor receptor binding and gene expression in vascular smooth muscle cells from SHR and WKY rats.
    Agrotis A, Saltis J, Bobik A.
    Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):145-8. PubMed ID: 7518757
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of vascular smooth muscle cell proliferation by DNA-RNA chimeric hammerhead ribozyme targeting to rat platelet-derived growth factor A-chain mRNA.
    Hu WY, Fukuda N, Nakayama M, Kishioka H, Kanmatsuse K.
    J Hypertens; 2001 Feb; 19(2):203-12. PubMed ID: 11212962
    [Abstract] [Full Text] [Related]

  • 11. Effects of the L- and N-type calcium channel blocker cilnidipine on growth of vascular smooth muscle cells from spontaneously hypertensive rats.
    Hu WY, Fukuda N, Su JZ, Kanmatsuse K.
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):450-9. PubMed ID: 11486249
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Vascular smooth muscle growth in genetic hypertension: evidence for multiple abnormalities in growth regulatory pathways.
    Saltis J, Bobik A.
    J Hypertens; 1992 Jul; 10(7):635-43. PubMed ID: 1321190
    [Abstract] [Full Text] [Related]

  • 14. The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rats.
    Rosen B, Barg J, Zimlichman R.
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1243-51. PubMed ID: 10619588
    [Abstract] [Full Text] [Related]

  • 15. Altered signalling in vascular smooth muscle from spontaneously hypertensive rats may link medial hypertrophy, vessel hyperinnervation and elevated nerve growth factor.
    Tuttle JB, Spitsbergen JM, Stewart JS, McCarty RM, Steers WD.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S117-9. PubMed ID: 9072319
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor-beta 1 proliferated vascular smooth muscle cells from spontaneously hypertensive rats.
    Sato M, Ohsaki Y, Tobise K.
    Am J Hypertens; 1995 Feb; 8(2):160-6. PubMed ID: 7755944
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Signaling mechanisms of basic fibroblast growth factor in arterial cells from genetically hypertensive rat.
    Zhu DL, Hérembert T, Caruelle D, Caruelle JP, Marche P.
    Am J Hypertens; 1994 Apr; 7(4 Pt 1):351-6. PubMed ID: 8031551
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.